Reducing Qiagen's Uncertainty Rating In Line With Life Sciences/Diagnostic Peers

Qiagen aims to help scientists and caregivers use biological samples to identify and solve problems related to DNA, RNA, and proteins, and these tools remain in high demand as the COVID-19 pandemic grinds on further. Qiagen's roots are in products that help scientists prepare biological samples for various experiments, and sample preparation products still accounted for 38% of sales in 2021, although slightly inflated as a percentage of sales due to the COVID-19 health crisis. Qiagen remains the undisputed leader in this niche, and we expect Qiagen to continue to invest to maintain that position, despite that end market's ongoing growth prospects in the low single digits.